With 4 more filings in 3QFY17, TRP has now filed 10 ANDAs in the US on YTD basis and is on track to meet its earlier guidance of 15 filings in FY17. Notably, these filings include 2 derma and 2 FTFs. TRP?s pipeline build up program is likely to gain more momentum in FY18/FY19 with 40-45 filings over two years.